Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 92 of 144 pages ‹ First < 90 91 92 93 94 > Last ›
HSL4398
Otto M.
Bird flu threat not so grave, CDC chief says
The News Tribune ( Tacoma ) 2006 Apr 15
http://healthyskepticism.org/subscribers/library/news.php
HSL4979
Dyer O.
Nine drug company chiefs are charged with conspiracy to defraud NHS.
BMJ 2006 Apr 15; 332:(7546):872
http://bmj.bmjjournals.com/cgi/content/full/332/7546/872-c
HSL4980
Dyer O.
Disease awareness campaigns turn healthy people into patients.
BMJ 2006 Apr 15; 332:(7546):871
http://bmj.bmjjournals.com/cgi/content/full/332/7546/871
HSL7873
Healy D.
The myth of 'mood stabilising' drugs
New Scientist 2006 Apr 15; (2547):
http://www.newscientist.com/channel/health/mg19025471.200-the-myth-of-mood-stabilising-drugs.html;jsessionid=EGHGLKIFLFAK
HSL4517
Whelan J.
State mandates screening for postpartum depression
The Star-Ledger ( New Jersey) 2006 Apr 14
http://www.nj.com/news/ledger/jersey/index.ssf?/base/news-3/1144990778306650.xml&coll=1
HSL4521
Korn P.
Preschoolers put on ‘adult’ medication
Portland Tribune 2006 Apr 14
http://www.portlandtribune.com/archview.cgi?id=34841
HSL4434
Gumpert D.
Hormone Battle: Big Pharma vs. Small Biz
BusinessWeek Online 2006 Apr 13
http://www.businessweek.com/print/smallbiz/content/apr2006/sb20060413_667219.htm
HSL3927
Olsen G.
The Doctor Will See You Now
Medical Accountability Network 2006 Apr 12
http://www.medicalaccountability.net/PagesArticles/GwenOlsenEssay.html
HSL3933
Vedantam S.
Comparison of Schizophrenia Drugs Often Favors Firm Funding Study
Washington Post 2006 Apr 12
http://www.washingtonpost.com/wp-dyn/content/article/2006/04/11/AR2006041101478.html
HSL5066
Rane A.
[Drug committees should not recommend 'off label' prescriptions].
Lakartidningen 2006 Apr 12-25; 103:(15-16):1219
HSL5561
Sesardic D.
Regulatory considerations on new adjuvants and delivery systems.
Vaccine 2006 Apr 12; 24:
HSL3925
A Collection of Articles on Disease Mongering
PLoS Medicine ( Public Library of Science) 2006 Apr 11
http://collections.plos.org/diseasemongering-2006.php
HSL3926
Henry D, Moynihan R.
Inaugural Conference on Disease-Mongering
diseasemongering.org 2006 Apr 11
http://www.diseasemongering.org/
HSL3929
Dreaper J.
UK Vioxx cases await court hearing
BBC News 2006 Apr 11
http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/4901030.stm
HSL4516
Roner L.
DTC spending to slow, channels changing
Eye For Pharma 2006 Apr 11
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=4/13/2006&news=50526
HSL4981
Lexchin J.
Do manufacturers of brand-name drugs engage in price competition? An analysis of introductory prices
CMAJ 2006 Apr 11; 174:(8):1120-1
http://www.cmaj.ca/cgi/content/full/174/8/1120
HSL3931
Evans D.
Parexel Misled Subjects Sickened in London Study, Ethicists Say
Bloomberg 2006 Apr 10
http://www.bloomberg.com/apps/news?pid=10000100&sid=aG3sg1rIkL4U&refer=germany
HSL4512
Wolfe S.
Public Citizen Petitions FDA to Ban Xenical (orlistat)
Public Citizen 2006 Apr 10
http://www.citizen.org/pressroom/release.cfm?ID=2174
HSL5039
Benko LB.
Drug lawsuits building. Merck, Pfizer facing charges of misrepresentation.
Mod Healthc 2006 Apr 10; 36:(15):16
HSL3932
Altman L.
Blasting of Kidney Stones Has Risks, Study Reports
New York Times 2006 Apr 9
http://www.nytimes.com/glogin?URI=http://www.nytimes.com/2006/04/10/health/10kidney.html&OQ=_rQ3D1&OP=102e21b6Q2FQ5BF6WQ5BQ3AQ5Ep5fQ5EQ5En,Q5B,((UQ5B(Q2AQ5B9(Q5Bd6hsndQ5B9(Q27Q24Q3Ai6zQ51dngs
HSL3923
Rosenthal E.
British Rethinking Rules After Ill-Fated Drug Trial
New York Times 2006 Apr 8
http://www.nytimes.com/2006/04/08/world/europe/08britain.html?_r=1&th=&oref=slogin&emc=th&pagewanted=print
HSL5068
Rosenthal E.
British rethinking test rules after drug trial nearly kills 6.
NY Times (Print) 2006 Apr 8; A1:
HSL3922
Pringle E.
Kids on ADHD drugs: A dangerous path to addiction
Online Journal 2006 Apr 7
http://onlinejournal.com/artman/publish/printer_672.shtml
HSL5466
Mansfield PR.
Universal Hepatitis-B Vaccination in India: A Questionable Strategy
BMJ 2006 Apr 7; 302:
http://bmj.bmjjournals.com/cgi/eletters/332/7545/804
HSL5828
Mangan KS.
Researchers raise concerns about secrecy in company-sponsored clinical trials.
Chron High Educ 2006 Apr 7; 52:(31):A29
HSL3928
Ismail M.
Deep Pockets Contribute to Success- Industry spends millions on state campaign donations, Calif. fight
The Center for Public Integrity 2006 Apr 6
http://www.publicintegrity.org/rx/report.aspx?aid=795
HSL3930
Driver A.
Merck ex-CEO denies hiding Vioxx data from FDA
Reuters 2006 Apr 6
http://news.moneycentral.msn.com/provider/providerarticle.asp?Feed=OBR&Date=20060406&ID=5624350
HSL4433
Sellers of Children’s Weight-Loss Product Settle FTC Charges
Federal Trade Commission 2006 Apr 6
http://www.ftc.gov/opa/2006/04/dynamichealth.htm
HSL3924
Baker J.
U.K. Parexel International Statement Regarding Tegenero AG Phase I Trial at Northwick Park Hospital
Parexel International 2006 Apr 5
http://www.parexel.com/news_and_events/press_releasesSingle.asp?id=236
HSL20199
Jenkins R
Fight direct drug ads, GPs told
Australian Doctor 2006 Apr 53
http://www.australiandoctor.com.au/news/latest-news/fight-direct-drug-ads,-gps-told
HSL3921
190 Pharmaceutical Companies Might Receive Subpoenas In Anti-Competitive Practices Investigation, FTC Says
kaisernetwork.org ( The Henry J. Kaiser Family Foundation) 2006 Apr 3
http://www.medicalnewstoday.com/medicalnews.php?newsid=40692
HSL8521
Roughead EE, Lexchin J.
Adverse drug events: counting is not enough, action is needed.
Med J Aust 2006 Apr 3; 184:(7):315-6
http://www.mja.com.au/public/issues/184_07_030406/rou10066_fm.html
HSL5889
Scarborough J.
Bayer sold HIV infected blood product
You Tube 2006 Apr 2
http://www.youtube.com/watch?v=XS3mhjt7TrY&search=Bayer
HSL3850
Elliott C.
The Drug Pushers
The Atlantic Monthly 2006 Apr 1
http://www.theatlantic.com/doc/prem/200604/drug-reps
HSL3898
Hall KB, Tett SE, Nissen LM.
Perceptions of the Influence of Prescription Medicine Samples on Prescribing by Family Physicians.
Med Care 2006 Apr 1; 44:(4):383-387
http://www.lww-medicalcare.com/pt/re/medcare/abstract.00005650-200604000-00014.htm
HSL3920
Jureidini J.
Systematic checks can avert crisis from adverse drug reactions
The Australian Newspaper 2006 Apr 1
http://www.theaustralian.news.com.au/common/story_page/0,5744,18666410%255E23289,00.html
HSL4531
Cassels A.
Depressed or anxious? Switching pills for your ills a dangerous practice
Common Ground (Vancouver) 2006 Apr 1
http://www.commonground.ca/iss/0604177/cg177_cassels.shtml
HSL4870
Breckenridge A, Dollery C, Rawlins M, Walport M.
The future of clinical pharmacology in the UK.
Lancet 2006 Apr 1; 367:(9516):1051
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16581393&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)68460-2
HSL5063
Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R.
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.
BMJ 2006 Apr 1; 332:(7544):756-61
http://bmj.bmjjournals.com/cgi/content/full/332/7544/756
HSL5154
Abbasi K.
Unconvincing Pfizer and uncertain crucifixions.
J R Soc Med 2006 Apr 01; 99:(4):163
http://www.jrsm.org/cgi/content/full/99/4/163
HSL5174
Davis RL, Khoury MJ.
A public health approach to pharmacogenomics and gene-based diagnostic tests.
Pharmacogenomics 2006 Apr 01; 7:(3):331-7
http://www.futuremedicine.com/doi/abs/10.2217/14622416.7.3.331
HSL5214
Genzyme launches diagnostic to monitor Gleevec resistance.
Pharmacogenomics 2006 Apr 01; 7:(3):267
http://www.futuremedicine.com/doi/abs/10.2217/14622416.7.3.267
HSL5215
Sullivan EE.
The propofol controversy.
J Perianesth Nurs 2006 Apr 01; 21:(2):128-30
http://linkinghub.elsevier.com/retrieve/pii/S1089-9472(06)00046-3
HSL5216
Odom-Forren J.
The propofol debate continues.
J Perianesth Nurs 2006 Apr 01; 21:(2):77-8
http://linkinghub.elsevier.com/retrieve/pii/S1089-9472(06)00078-5
HSL5393
Cooke CE, Hammerash WJ Jr.
Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
Clin Ther 2006 Apr 01; 28:(4):591-9
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-4K47N6F-D&_coverDate=04%2F30%2F2006&_alid=421181668&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=7c3e59d9d810e211b8cc28ae1feca2cb
HSL5418
Kline AD.
On complicity theory.
Sci Eng Ethics 2006 Apr 01; 12:(2):257-64
HSL5432
Edwards SJ.
Restricted treatments, inducements, and research participation.
Bioethics 2006 Apr 01; 20:(2):77-91
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1467-8519.2006.00479.x
HSL5436
Klein CA.
Dispensing pharmaceutical samples: a few reminders.
Nurse Pract 2006 Apr 01; 31:(4):15
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00006205-200604000-00004
HSL5465
Mansfield PR, Phadke A, Kale A.
Blanket hepatitis B vaccination is questionable in India
BMJ 2006 Apr 1; 332:(7547):976
HSL5540
Laughren T, Levin R
Food and drug administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim
Schizophrenia Bulletin 2006 Apr 01; 32:(2):220-222
http://schizophreniabulletin.oxfordjournals.org/cgi/content/abstract/32/2/220
HSL5542
Klein , Donald F.
The flawed basis for FDA post-marketing safety decisions: The example of anti-depressants and children
Neuropsychopharmacology 2006 Apr 01; 31:(4):689-699
http://www.nature.com/npp/
HSL5776
Carter OB.
The weighty issue of Australian television food advertising and childhood obesity.
Health Promot J Austr 2006 Apr 01; 17:(1):5-11
HSL5931
Moncrieff J.
Psychiatric drug promotion and the politics of neo-liberalism.
Br J Psychiatry 2006 Apr 01; 188:301-2
http://bjp.rcpsych.org/cgi/content/full/188/4/301
HSL5932
Alo A.
Pharmacy in Nigeria.
Am J Health Syst Pharm 2006 Apr 1; 63:(7):670-3
http://www.ajhp.org/cgi/content/full/63/7/670
HSL5997
Rubinstein E.
Timeline and potential impact of CMS's drug competitive acquisition program (CAP).
J Manag Care Pharm 2006 Apr 01; 12:(3):263-4
HSL5998
Bickford CL, Spencer AP.
Adherence to the NASPE guideline for amiodarone monitoring at a medical university.
J Manag Care Pharm 2006 Apr 01; 12:(3):254-9
HSL6047
Ghebrehiwet T.
Counterfeits kill!
Imprint. 2006 Apr-May 01; 53:(3):40-4
HSL6056
Fitzpatrick M.
Big pharma--paper tiger.
Br J Gen Pract 2006 Apr 01; 56:(525):309
http://www.ingentaconnect.com/content/rcgp/bjgp/2006/00000056/00000525/art00024?token=0055154ebec22644a467b4d616d3f4e4b34496e586546244025425b475f5d3e706a707bc562c05d7ed43f
HSL6124
Aggett P.
Evidence based nutrition and health claims on foods: a renaissance?
Matern Child Nutr 2006 Apr 01; 2:(2):65-6
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1740-8709.2006.00056.x
HSL6145
Curry P, O'Brien M.
The male heart and the female mind: a study in the gendering of antidepressants and cardiovascular drugs in advertisements in Irish medical publication.
Soc Sci Med 2006 Apr 01; 62:(8):1970-7
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4H8MP4P-2&_coverDate=04%2F30%2F2006&_alid=458095777&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=2d8b763dd1b74e8916b1bf6594bde81a
HSL6188
Di Paolo ER, Stoetter H, Cotting J, Frey P, Gehri M, Beck-Popovic M, Tolsa JF, Fanconi S, Pannatier A.
Unlicensed and off-label drug use in a Swiss paediatric university hospital.
Swiss Med Wkly 2006 Apr 1; 136:(13-14):218-22
http://www.smw.ch/dfe/set_archiv.asp?target=2006/13/smw-11275
HSL6204
Alphs L.
An industry perspective on the NIMH consensus statement on negative symptoms.
Schizophr Bull 2006 Apr 01; 32:(2):225-30
http://schizophreniabulletin.oxfordjournals.org/cgi/content/full/32/2/225
HSL6398
Hackford R.
With the recent Food and Drug Administration (FDA) Advisory Committee's recommendation to put a black box warning on stimulants, the government has joined the media in raising alarm about the medical treatment of attention-deficit disorder.
J Dev Behav Pediatr 2006 Apr 01; 27:(2):179
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00004703-200604000-00020
HSL11545
Fox N, Ward K, O’Rourke A.
A Sociology of Technology Governance for the Information Age: The Case of Pharmaceuticals, Consumer Advertising and the Internet
Sociology 2006 Apr 1; 40:(2):315-334
http://soc.sagepub.com/cgi/content/abstract/40/2/315
HSL4044
Hill K.
Free Lunch?
The American Journal of Psychiatry 2006 Apr; (163):569-570
http://ajp.psychiatryonline.org/cgi/content/full/163/4/569
HSL5036
Debate over warnings for ADHD stimulants.
Child Health Alert 2006 Apr; 24:(1):
HSL5056
Moldrup C, Hansen RR.
Public acceptance of drug use for non-disease conditions.
Curr Med Res Opin 2006 Apr; 22:(4):775-80
http://www.ingentaconnect.com/content/libra/cmro/2006/00000022/00000004/art00017?token=005b1d8c135bf15a7f11d7627502b333e3568263c2b6f7e2a46762c47355d36766c254423795f7b37683b6dbe1a
HSL5057
Bestehorn K, Voller H, Benecke H, Renner H, Karmann B, Wegscheider K.
Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment.
Curr Med Res Opin 2006 Apr; 22:(4):631-9
http://www.ingentaconnect.com/content/libra/cmro/2006/00000022/00000004/art00002?token=005319c8e8d4e1ad24e75477e4324576b642738687b76504c48762a256a23562f424025595529bcadd1
HSL5062
Zuckerman IH, Lee E, Wutoh AK, Xue Z, Stuart B.
Application of regression-discontinuity analysis in pharmaceutical health services research.
Health Serv Res 2006 Apr; 41:(2):550-63
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1475-6773.2005.00487.x
HSL5070
Hirsch LJ.
Clinical trial registry initiative.
Bull World Health Organ 2006 Apr; 84:(4):336
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000400024&lng=en&nrm=iso&tlng=en
HSL5101
Christakis DA, Zimmerman FJ.
Media as a public health issue.
Arch Pediatr Adolesc Med 2006 Apr; 160:(4):445-6
http://archpedi.ama-assn.org/cgi/content/full/160/4/445
HSL5102
Chamberlain LJ, Wang Y, Robinson TN.
Does children's screen time predict requests for advertised products? Cross-sectional and prospective analyses.
Arch Pediatr Adolesc Med 2006 Apr; 160:(4):363-8
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16585480&db=PubMed&url=http://archpedi.ama-assn.org/cgi/pmidlookup?view=long&pmid=16585480
HSL5103
Martin A.
Stimulating: prescribing amidst controversy.
Am J Psychiatry 2006 Apr; 163:(4):574-7
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16585428&db=PubMed&url=http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=16585428
HSL5121
Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Freedman R.
Conflict of interest.
Am J Psychiatry 2006 Apr; 163:(4):571-3
http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=16585427
HSL7096
Smith PK, Fox AT, Davies P, Hamidi-Manesh L.
Cyberchondriacs.
Int J Adolesc Med Health 2006 Apr-Jun; 18:(2):209-13
HSL7256
Dunfee TW.
Do firms with unique competencies for rescuing victims of human catastrophes have special obligations?: Corporate responsibility and the AIDS catastrophe in sub-Saharan Africa
Bus Ethics Q. 2006 Apr; 16:(2):185-210
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17162832&query_hl=1&itool=pubmed_DocSum
HSL7529
Chokshi DA.
Improving access to medicines in poor countries: the role of universities.
PLoS Med 2006 Apr; 3:(6):e136
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030136
HSL7705
Tully MP, Cantrill JA.
The validity of explicit indicators of prescribing appropriateness.
Int J Qual Health Care 2006 Apr; 18:(2):87-94
http://intqhc.oxfordjournals.org/cgi/content/full/18/2/87
HSL7708
Schwartzberg E, Rubinovich S, Hassin D, Haspel J, Ben-Moshe A, Oren M, Shani S.
Developing and implementing a model for changing physicians' prescribing habits-- the role of clinical pharmacy in leading the change.
J Clin Pharm Ther 2006 Apr; 31:(2):179-85
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2006.00724.x
HSL7709
Wong WC, You JH.
The all-powerful and 'happy' drug: the use of steroids among primary care doctors in Hong Kong.
J Clin Pharm Ther 2006 Apr; 31:(2):173-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2710.2006.00721.x
HSL7710
Garcia RM.
Five ways you can reduce inappropriate prescribing in the elderly: a systematic review.
J Fam Pract 2006 Apr; 55:(4):305-12
http://www.jfponline.com/Pages.asp?AID=4011
HSL7713
Roughead EE, Zhang F, Ross-Degnan D, Soumerai S.
Differential effect of early or late implementation of prior authorization policies on the use of Cox II inhibitors.
Med Care 2006 Apr; 44:(4):378-82
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005650-200604000-00013
HSL7718
Kumar CJ, Deoker A, Kumar A, Kumar A, Hegde BM.
Awareness and attitudes about disease mongering among medical and pharmaceutical students.
PLoS Med 2006 Apr; 3:(4):e213
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030213
HSL7874
Moynihan R, Henry D.
The Fight against Disease Mongering: Generating Knowledge for Action
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030191
HSL7875
Lexchin J.
Bigger and Better: How Pfizer Redefined Erectile Dysfunction
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030132
HSL7876
Phillips CB.
Medicine Goes to School: Teachers as Sickness Brokers for ADHD
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030182
HSL7877
Tiefer L.
Female Sexual Dysfunction: A Case Study of Disease Mongering and Activist Resistance
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030178
HSL7878
Harris G.
The Latest Mania: Selling Bipolar Disorder
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030185
HSL7879
Applbaum K.
Pharmaceutical Marketing and the Invention of the Medical Consumer
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030189
HSL7880
Heath I.
Combating Disease Mongering: Daunting but Nonetheless Essential
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030146
HSL7881
Woloshin S, Schwartz LM.
Giving Legs to Restless Legs: A Case Study of How the Media Helps Make People Sick
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030170
HSL7882
Maggini M, Vanacore N, Raschetti R.
Cholinesterase Inhibitors: Drugs Looking for a Disease?
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030140
HSL7883
Mintzes B.
Disease Mongering in Drug Promotion: Do Governments Have a Regulatory Role?
PLoS Med 2006 Apr; 3:(4):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030198
HSL8582
Moynihan R, Burne M
Motivational Deficiency Disorder (Video)
: Ray & MJ Productions 2006 Apr
http://www.youtube.com/watch?v=RoppJOtRLe4
HSL8793
Abraham J, Davis C.
Testing times: the emergence of the practolol disaster and its challenge to British drug regulation in the modern period.
Soc Hist Med 2006 Apr; 19:(1):127-47
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17153164&query_hl=4&itool=pubmed_DocSum
HSL9102
William-Jones B.
'Be ready against cancer, now': direct-to-consumer advertising for genetic testing.
New Genet Soc 2006 Apr; 25:(1):89-107
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17312631&query_hl=11&itool=pubmed_DocSum
HSL10196
Canli H, Saatci E, Bozdemir N, Akpinar E, Kiroglu M.
The antibiotic prescribing behaviour of physicians for acute tonsillopharyngitis in primary care.
Ethiop Med J 2006 Apr; 44:(2):139-43
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17447376&query_hl=12&itool=pubmed_DocSum
HSL10906
Jones B.
Adaptive design: a concept whose time has come.
Pharm Stat 2006 Apr-Jun; 5:(2):83-4
http://ieeexplore.ieee.org/search/wrapper.jsp?arnumber=4015494
HSL12040
Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
Am J Psychiatry 2006 Apr; 163:(4):611-22
http://ajp.psychiatryonline.org/cgi/content/full/163/4/611
HSL13368
Barden J, Derry S, McQuay HJ, Moore RA.
Bias from industry trial funding? A framework, a suggested approach, and a negative result
Pain. 2006 Apr Epub Feb 21; 121:(3):207-18
http://linkinghub.elsevier.com/retrieve/pii/S0304-3959(05)00609-3
Page 92 of 144 pages ‹ First < 90 91 92 93 94 > Last ›
